Yahoo
NYSE - Nasdaq Real Time Price USD

Avantor, Inc. (AVTR)

15.84 -0.22 (-1.40%)
As of 9:48:42 AM EST. Market Open.
Trade Avantor on Coinbase
Chart Range Bar
Loading chart for AVTR
  • Previous Close 16.06
  • Open 16.09
  • Bid 16.00 x 420000
  • Ask 16.04 x 150000
  • Day's Range 15.78 - 16.07
  • 52 Week Range 7.26 - 17.45
  • Volume 455,409
  • Avg. Volume 8,716,343
  • Market Cap (intraday) 10.73B
  • Beta (5Y Monthly) 0.95
  • PE Ratio (TTM) 31.58
  • EPS (TTM) 0.50
  • Earnings Date Oct 28, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 17.35
  • Zacks Rating Neutral

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.

www.avantorsciences.com

13,500

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

AVTR
37.78%
S&P 500 (^GSPC)
11.37%

1-Year Return

AVTR
33.59%
S&P 500 (^GSPC)
11.46%

3-Year Return

AVTR
13.24%
S&P 500 (^GSPC)
76.57%

5-Year Return

AVTR
60.36%
S&P 500 (^GSPC)
64.64%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.7B
Earnings 203.4M
Profit Margin 11.98%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
4.0%
6.0%
8.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

16.00
17.35 Average
15.84 Current
19.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 10/29/2026
Analyst RBC Capital
Rating Action Maintains
Rating Sector Perform
Price Action Raises
Price Target 14 -> 17

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.08%

  • Return on Assets (ttm)

    2.83%

  • Return on Equity (ttm)

    5.91%

  • Revenue (ttm)

    6.64B

  • Net Income Avi to Common (ttm)

    337.2M

  • Diluted EPS (ttm)

    0.50

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    464.3M

  • Total Debt/Equity (mrq)

    63.12%

  • Levered Free Cash Flow (ttm)

    440.88M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: